Stryker Corp
NYSE:SYK

Watchlist Manager
Stryker Corp Logo
Stryker Corp
NYSE:SYK
Watchlist
Price: 389.71 USD 1.25% Market Closed
Market Cap: 148.6B USD
Have any thoughts about
Stryker Corp?
Write Note

Net Margin
Stryker Corp

16.3%
Current
14%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
16.3%
=
Net Income
3.6B
/
Revenue
22B

Net Margin Across Competitors

Country US
Market Cap 148.6B USD
Net Margin
16%
Country US
Market Cap 205.2B USD
Net Margin
14%
Country US
Market Cap 193.1B USD
Net Margin
29%
Country US
Market Cap 132.9B USD
Net Margin
11%
Country IE
Market Cap 109.9B USD
Net Margin
13%
Country US
Market Cap 64.8B USD
Net Margin
9%
Country DE
Market Cap 56.7B EUR
Net Margin
8%
Country CN
Market Cap 325.5B CNY
Net Margin
33%
Country US
Market Cap 42.2B USD
Net Margin
74%
Country US
Market Cap 37.7B USD
Net Margin
9%
Country US
Market Cap 36.7B USD
Net Margin
23%
No Stocks Found

Stryker Corp
Glance View

Market Cap
148.6B USD
Industry
Health Care

Stryker Corporation, a prominent player in the global medical technology landscape, has carved out a reputation for innovation and reliability since its founding in 1941. Specializing in developing and manufacturing a diverse range of products, Stryker's offerings span surgical equipment, implantable devices, and medical instruments, all designed to enhance patient care and improve clinical outcomes. Fueled by a commitment to quality and continuous improvement, the company invests heavily in research and development, leading the way with cutting-edge technologies like robotic surgical systems and advanced orthopedic solutions. The company’s strong market position is bolstered by its strategic acquisitions, which not only expand its product portfolio but also deepen its penetration into key medical segments, allowing Stryker to sustain impressive growth rates. For investors, Stryker represents a compelling opportunity in the healthcare sector, driven by the increasing demand for advanced medical solutions in an aging global population. With a presence in over 100 countries, Stryker's diversified revenue streams reduce risk and enhance resilience against market fluctuations. The company consistently delivers solid financial performance, characterized by robust margins and healthy cash flows, which it strategically reinvests to fuel future growth. Furthermore, its strong commitment to sustainability and corporate responsibility positions Stryker favorably in a market increasingly concerned with ethical practices. As the healthcare industry continues to evolve, Stryker’s innovative edge and solid fundamentals make it a captivating prospect for investors seeking long-term stability and growth.

SYK Intrinsic Value
290.55 USD
Overvaluation 25%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
16.3%
=
Net Income
3.6B
/
Revenue
22B
What is the Net Margin of Stryker Corp?

Based on Stryker Corp's most recent financial statements, the company has Net Margin of 16.3%.